David Kirn
Overview
David Kirn received an average of $4M in total compensation, including $527K in salary, at 4D Molecular Therapeutics from 2019 to 2023.
Source: SEC filings on April 10, 2024, April 12, 2023, April 13, 2022, and April 6, 2021.
Related executives
We found six more executives who work or worked at 4D Molecular Therapeutics.
Fariborz Kamal
4D Molecular Therapeutics
Chief Operating Officer
Robert Kim
4D Molecular Therapeutics
Chief Medical Officer
August Moretti
4D Molecular Therapeutics
Chief Financial Officer
August Moretti
4D Molecular Therapeutics
Chief Financial Officer
Theresa Janke
4D Molecular Therapeutics
Chief of Staff
Robert Fishman
4D Molecular Therapeutics
Chief Medical Officer
News
4D Molecular Therapeutics CEO David Kirn's 2023 pay jumps 213% to $10M
April 10, 2024
4D Molecular Therapeutics CEO David Kirn's 2022 pay falls 37% to $3.3M
April 12, 2023
4D Molecular Therapeutics CEO David Kirn's 2021 pay jumps 641% to $5.2M
April 13, 2022
4D Molecular Therapeutics Chief Medical Officer Robert Fishman receives $3.3M in 2020
April 6, 2021